Cargando…

L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach

BACKGROUND/AIMS: The neural cell adhesion molecule L1CAM is a transmembrane glycoprotein abnormally expressed in tumors and previously associated with cell proliferation, adhesion and invasion, as well as neurite outgrowth in endometriosis. Being an attractive target molecule for antibody-based ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Silveira, Cássia G. T., Finas, Dominique, Hunold, Peter, Köster, Frank, Stroschein, Katharina, Canny, Geraldine O., Moldenhauer, Gerhard, Altevogt, Peter, Rody, Achim, Hornung, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853202/
https://www.ncbi.nlm.nih.gov/pubmed/24324802
http://dx.doi.org/10.1371/journal.pone.0082512
_version_ 1782478796660670464
author Silveira, Cássia G. T.
Finas, Dominique
Hunold, Peter
Köster, Frank
Stroschein, Katharina
Canny, Geraldine O.
Moldenhauer, Gerhard
Altevogt, Peter
Rody, Achim
Hornung, Daniela
author_facet Silveira, Cássia G. T.
Finas, Dominique
Hunold, Peter
Köster, Frank
Stroschein, Katharina
Canny, Geraldine O.
Moldenhauer, Gerhard
Altevogt, Peter
Rody, Achim
Hornung, Daniela
author_sort Silveira, Cássia G. T.
collection PubMed
description BACKGROUND/AIMS: The neural cell adhesion molecule L1CAM is a transmembrane glycoprotein abnormally expressed in tumors and previously associated with cell proliferation, adhesion and invasion, as well as neurite outgrowth in endometriosis. Being an attractive target molecule for antibody-based therapy, the present study assessed the ability of the monoclonal anti-L1 antibody (anti-L1 mAb) to impair the development of endometriotic lesions in vivo and endometriosis-associated nerve fiber growth. METHODS AND RESULTS: Endometriosis was experimentally induced in sexually mature B6C3F1 (n=34) and CD-1 nude (n=21) mice by autologous and heterologous transplantation, respectively, of endometrial fragments into the peritoneal cavity. Transplantation was confirmed four weeks post-surgery by in vivo magnetic resonance imaging and laparotomy, respectively. Mice were then intraperitoneally injected with anti-L1 mAb or an IgG isotype control antibody twice weekly, over a period of four weeks. Upon treatment completion, mice were sacrificed and endometrial implants were excised, measured and fixed. Endometriosis was histologically confirmed and L1CAM was detected by immunohistochemistry. Endometriotic lesion size was significantly reduced in anti-L1-treated B6C3F1 and CD-1 nude mice compared to mice treated with control antibody (P<0.05). Accordingly, a decreased number of PCNA positive epithelial and stromal cells was detected in autologously and heterologously induced endometriotic lesions exposed to anti-L1 mAb treatment. Anti-L1-treated mice also presented a diminished number of intraperitoneal adhesions at implantation sites compared with controls. Furthermore, a double-blind counting of anti-neurofilament L stained nerves revealed significantly reduced nerve density within peritoneal lesions in anti-L1 treated B6C3F1 mice (P=0.0039). CONCLUSIONS: Local anti-L1 mAb treatment suppressed endometriosis growth in B6C3F1 and CD-1 nude mice and exerted a potent anti-neurogenic effect on induced endometriotic lesions in vivo. The findings of this preliminary study in mice provide a strong basis for further testing in in vivo models.
format Online
Article
Text
id pubmed-3853202
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38532022013-12-09 L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach Silveira, Cássia G. T. Finas, Dominique Hunold, Peter Köster, Frank Stroschein, Katharina Canny, Geraldine O. Moldenhauer, Gerhard Altevogt, Peter Rody, Achim Hornung, Daniela PLoS One Research Article BACKGROUND/AIMS: The neural cell adhesion molecule L1CAM is a transmembrane glycoprotein abnormally expressed in tumors and previously associated with cell proliferation, adhesion and invasion, as well as neurite outgrowth in endometriosis. Being an attractive target molecule for antibody-based therapy, the present study assessed the ability of the monoclonal anti-L1 antibody (anti-L1 mAb) to impair the development of endometriotic lesions in vivo and endometriosis-associated nerve fiber growth. METHODS AND RESULTS: Endometriosis was experimentally induced in sexually mature B6C3F1 (n=34) and CD-1 nude (n=21) mice by autologous and heterologous transplantation, respectively, of endometrial fragments into the peritoneal cavity. Transplantation was confirmed four weeks post-surgery by in vivo magnetic resonance imaging and laparotomy, respectively. Mice were then intraperitoneally injected with anti-L1 mAb or an IgG isotype control antibody twice weekly, over a period of four weeks. Upon treatment completion, mice were sacrificed and endometrial implants were excised, measured and fixed. Endometriosis was histologically confirmed and L1CAM was detected by immunohistochemistry. Endometriotic lesion size was significantly reduced in anti-L1-treated B6C3F1 and CD-1 nude mice compared to mice treated with control antibody (P<0.05). Accordingly, a decreased number of PCNA positive epithelial and stromal cells was detected in autologously and heterologously induced endometriotic lesions exposed to anti-L1 mAb treatment. Anti-L1-treated mice also presented a diminished number of intraperitoneal adhesions at implantation sites compared with controls. Furthermore, a double-blind counting of anti-neurofilament L stained nerves revealed significantly reduced nerve density within peritoneal lesions in anti-L1 treated B6C3F1 mice (P=0.0039). CONCLUSIONS: Local anti-L1 mAb treatment suppressed endometriosis growth in B6C3F1 and CD-1 nude mice and exerted a potent anti-neurogenic effect on induced endometriotic lesions in vivo. The findings of this preliminary study in mice provide a strong basis for further testing in in vivo models. Public Library of Science 2013-12-04 /pmc/articles/PMC3853202/ /pubmed/24324802 http://dx.doi.org/10.1371/journal.pone.0082512 Text en © 2013 Silveira et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Silveira, Cássia G. T.
Finas, Dominique
Hunold, Peter
Köster, Frank
Stroschein, Katharina
Canny, Geraldine O.
Moldenhauer, Gerhard
Altevogt, Peter
Rody, Achim
Hornung, Daniela
L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach
title L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach
title_full L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach
title_fullStr L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach
title_full_unstemmed L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach
title_short L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach
title_sort l1 cell adhesion molecule as a potential therapeutic target in murine models of endometriosis using a monoclonal antibody approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853202/
https://www.ncbi.nlm.nih.gov/pubmed/24324802
http://dx.doi.org/10.1371/journal.pone.0082512
work_keys_str_mv AT silveiracassiagt l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT finasdominique l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT hunoldpeter l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT kosterfrank l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT stroscheinkatharina l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT cannygeraldineo l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT moldenhauergerhard l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT altevogtpeter l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT rodyachim l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach
AT hornungdaniela l1celladhesionmoleculeasapotentialtherapeutictargetinmurinemodelsofendometriosisusingamonoclonalantibodyapproach